Inflammatory markers in exhaled breath condensate following lung resection for bronchial carcinoma

Respirology

Volumn 13, Issue 7, 2008, Pages 1022-1027

  Jungraithmayr, Wolfgang ^a,c   Frings, Christina ^a   Zissel, Gernot ^a   Prasse, Antje ^a   Passlick, Bernward ^a   Stoelben, Erich ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Hospital Merheim   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Exhaled breath condensate; Inflammatory mediator; Lung carcinoma; Pulmonary resection

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FORCED EXPIRATORY VOLUME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LOBECTOMY; LUNG CARCINOMA; LUNG RESECTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY FAILURE; THORACOSCOPY; THORAX SURGERY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BIOPSY; BREATH TESTS; CARCINOMA, BRONCHOGENIC; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXHALATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONECTOMY; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; THORACOSCOPY;

EID: 54349111384     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01391.x     Document Type: Article

References (26)

1. Kutlu CA, Williams EA, Evans TW, Pastorino U, Goldstraw P. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Ann. Thorac. Surg. 2000 69 : 376 80.
2. Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am. J. Respir. Crit. Care Med. 1996 153 : 1850 6.
3. Borden EC, Chin P. Interleukin-6: a cytokine with potential diagnostic and therapeutic roles. J. Lab. Clin. Med. 1994 123 : 824 9.
4. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993 341 : 643 7.
5. Mendez MP, Morris SB, Wilcoxen S, Greeson E, Moore B et al. Shedding of soluble ICAM-1 into the alveolar space in murine models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006 290 : 962 70.
6. Parsons PE, Moore FA, Moore EE, Ikle DN, Henson PM et al. Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1992 146 : 694 700.
7. Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 2001 164 : 1896 903.
8. Parsons PE, Moss M, Vannice JL, Moore EE, Moore FA et al. Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. Am. J. Respir. Crit. Care Med. 1997 155 : 1469 73.
9. Scheideler L, Manke HG, Schwulera U, Inacker O, Hammerle H. Detection of nonvolatile macromolecules in breath. A possible diagnostic tool? Am. Rev. Respir. Dis. 1993 148 : 778 84.
10. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am. J. Respir. Crit. Care Med. 2001 163 : 1693 722.
11. Mutlu GM, Garey KW, Robbins RA, Danziger LH, Rubinstein I. Collection and analysis of exhaled breath condensate in humans. Am. J. Respir. Crit. Care Med. 2001 164 : 731 7.
12. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J. Allergy Clin. Immunol. 2002 110 : 28 34.
13. Emelyanov A, Fedoseev G, Abulimity A, Rudinski K, Fedoulov A et al. Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest 2001 120 : 1136 9.
14. Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2003 167 : 1109 12.
15. Loukides S, Horvath I, Wodehouse T, Cole PJ, Barnes PJ. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am. J. Respir. Crit. Care Med. 1998 158 : 991 4.
16. Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8 isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003 58 : 294 8.
17. Kietzmann D, Kahl R, Muller M, Burchardi H, Kettler D. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med. 1993 19 : 78 81.
18. Lases EC, Duurkens VA, Gerritsen WB, Haas FJ. Oxidative stress after lung resection therapy: A pilot study. Chest 2000 117 : 999 1003.
19. Moloney ED, Mumby SE, Gajdocsi R, Cranshaw JH, Kharitonov SA et al. Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery. Am. J. Respir. Crit. Care Med. 2004 169 : 64 9.
20. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E et al. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur. Respir. J. 2003 21 : 589 93.
21. Garey KW, Neuhauser MM, Robbins RA, Danziger LH, Rubinstein I. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 2004 125 : 22 6.
22. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995 107 : 1062 73.
23. Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga CH et al. Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 2004 127 : 1502 8.
24. Dubaybo BA, Bayasi G, Rubeiz GJ. Changes in tumor necrosis factor in postpneumonectomy lung growth. J. Thorac. Cardiovasc. Surg. 1995 110 : 396 404.
25. De Vita F, Orditura M, Infusino S, Auriemma A, Catalano G. Increased serum levels of tumor necrosis factor-alpha are correlated to soluble intercellular adhesion molecule-1 concentrations in non-small cell lung cancer patients. Int. J. Mol. Med. 1998 1 : 605 8.
26. Sprenger A, Schardt C, Rotsch M, Zehrer M, Wolf M et al. Soluble intercellular adhesion molecule-1 in patients with lung cancer and benign lung diseases. J. Cancer Res. Clin. Oncol. 1997 123 : 632 8.